Clal Insurance Enterprises Holdings LTD Abbott Laboratories Transaction History
Clal Insurance Enterprises Holdings LTD
- $11.1 Billion
- Q4 2024
A detailed history of Clal Insurance Enterprises Holdings LTD transactions in Abbott Laboratories stock. As of the latest transaction made, Clal Insurance Enterprises Holdings LTD holds 32 shares of ABT stock, worth $4,317. This represents 0.0% of its overall portfolio holdings.
Number of Shares
32Holding current value
$4,317% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ABT
# of Institutions
3,361Shares Held
1.36BCall Options Held
10.6MPut Options Held
8.73M-
Vanguard Group Inc Valley Forge, PA169MShares$22.8 Billion0.34% of portfolio
-
Black Rock Inc. New York, NY131MShares$17.7 Billion0.31% of portfolio
-
State Street Corp Boston, MA77.2MShares$10.4 Billion0.35% of portfolio
-
Capital International Investors Los Angeles, CA68MShares$9.17 Billion1.51% of portfolio
-
Capital Research Global Investors Los Angeles, CA54.1MShares$7.3 Billion1.31% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $236B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...